The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies—“Classical papillary” and “papillary‐like”, with different pathobiologic characteristics
Cancer Cytopathology · 2026-05 · 134 (5)
DOI: 10.1002/cncy.70100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cytopathology, online erschienen am 22.04.2026. Verfasst von N Paul Ohori und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh and UPMC-Presbyterian, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Follicular, Carcinoma, Carcinoma, Papillary, Cell Nucleus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The nucleus of papillary thyroid carcinoma (PTC) has had a fascinating history since its early descriptions by Lindsay in 1960 and his designation of follicular variant papillary thyroid carcinoma (FVPTC) as a subtype of follicular carcinoma (FC). Later, Chen and Rosai revived the awareness of FVPTC and aligned this neoplasm with PTC. From this era, PTC became a “nuclear” diagnosis and was expanded to include FVPTC, even when noninvasive and encapsulated. However, this practice was prone to interobserver variability. The main issue centered on the interpretation of two types of nuclei – the widely accepted “classical papillary nucleus” with well‐developed features such as nuclear pseudoinclusions and grooves and the other “papillary‐like nucleus” with subtle and delicate nuclear features. Subsequently, some individuals recognized “papillary‐like nucleus” in most follicular‐patterned neoplasms and diagnosed them as FVPTC, while others diagnosed them as follicular adenoma or FC. In the 2000s, noninvasive, encapsulated FVPTC was recognized as an indolent entity, and later relabeled as noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP). Molecular analyses revealed two main families of drivers for PTC ‐ BRAF V600E or BRAF V600E–like mutations which aligned with “classical papillary nucleus”, papillary architecture, and conventional PTC outcomes, and RAS or RAS–like mutations that were associated with “papillary‐like nucleus”, follicular architecture, and follicular‐patterned neoplasm outcomes. The story has made full circle and the recent proposal to incorporate FVPTC into FC is in keeping with Lindsay’s original concept. By our current understanding, these nuclei are classified better by molecular associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Pittsburgh and UPMC-Presbyterian, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: N Paul Ohori, Yuri E Nikiforov
Zitieren
APA
Ohori, N. P., Minkowitz, J. M., Nikiforov, Y. E., & Seethala, R. R. (2026). The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies—“Classical papillary” and “papillary‐like”, with different pathobiologic characteristics. Cancer Cytopathology, 134(5). https://doi.org/10.1002/cncy.70100
Vancouver
Ohori NP, Minkowitz JM, Nikiforov YE, Seethala RR. The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies—“Classical papillary” and “papillary‐like”, with different pathobiologic characteristics. Cancer Cytopathology. 2026;134(5). doi:10.1002/cncy.70100
BibTeX
@article{Ohori2026,
author = {Ohori, N Paul and Minkowitz, Jeremy M and Nikiforov, Yuri E and Seethala, Raja R},
title = {The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies—“Classical papillary” and “papillary‐like”, with different pathobiologic characteristics},
journal = {Cancer Cytopathology},
year = {2026},
volume = {134},
number = {5},
doi = {10.1002/cncy.70100}
}
EUVIMED